Company / Current Liabilities
Arcturus Therapeutics Holdings Inc. Current Liabilities History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$36.4M
FY2025
5-year range
$36.4M / $127.0M
FY2021-FY2025
Trend
-44.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has declined for 3 consecutive years, from $127M in FY2022 to $36M in FY2025.
Based on SEC 10-K filings.
$36M in FY2025 with a 5-year CAGR of -6.0%.
Improved from $82M to $36M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -34.1%
- 5-Year CAGR
- -6.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- Arcturus Therapeutics Holdings Inc.'s current liabilities has declined for 3 consecutive years.
- 5-year CAGR of -6.0%, indicating a declining trend.
- In FY2025, current liabilities decreased 44.5% year-over-year.
- Peak current liabilities was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $36.4M | -44.5% |
| FY2024 | $65.5M | -20.1% |
| FY2023 | $82.0M | -35.4% |
| FY2022 | $127.0M | +27.6% |
| FY2021 | $99.5M | +101.0% |
| FY2020 | $49.5M | +132.2% |
| FY2019 | $21.3M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026